Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
Researchers have identified a protein that, when present in high amounts in breast cancer tumors, is an indicator of whether DNA-damaging therapies will work or not.
Nov 23, 2022
0
78
University of Southampton scientists have made a breakthrough in understanding why some cancers don't respond to immunotherapy treatment, bringing fresh hope that many more people could survive the disease.
Nov 10, 2022
0
39
Northwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell proliferation and survival in acute myeloid leukemia (AML), according to a Northwestern Medicine study ...
Nov 4, 2022
0
11
Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs. ...
Oct 27, 2022
0
33
Scientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment—raising the possibility of outsmarting cancer by predicting drug resistance in advance.
Oct 25, 2022
0
32
Every year, more than 20,000 Australians—mostly women—are diagnosed with breast cancer. If you're one of them or know someone who is, the great news is that 92 out of every 100 women will survive for five years or more ...
Oct 20, 2022
0
0
Finding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Yang's lab at Baylor College of Medicine. In a study published in the Proceedings of the National Academy of Sciences, ...
Oct 17, 2022
0
117
Scientists have solved a long-standing mystery surrounding a cancer-promoting protein and how it causes tumor growth. The findings are an important step in the quest to make cancer drugs more effective since aggressive tumors ...
Oct 12, 2022
0
14
In a new study published in Molecular Cancer Research, Mayo Clinic researchers identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable ...
Sep 22, 2022
0
31
